News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,074 Results
Type
Article (85646)
Company Profile (699)
Press Release (746729)
Section
Business (232255)
Career Advice (4110)
Deals (39654)
Drug Delivery (121)
Drug Development (90682)
Employer Resources (194)
FDA (17972)
Job Trends (17274)
News (395582)
Policy (39625)
Tag
Academia (2974)
Alliances (56527)
Alzheimer's disease (1354)
Approvals (17891)
Artificial intelligence (170)
Bankruptcy (394)
Best Places to Work (12545)
Biotechnology (483)
Breast cancer (193)
Cancer (1396)
Cardiovascular disease (120)
Career advice (3515)
Cell therapy (304)
Clinical research (71865)
Collaboration (477)
Compensation (250)
COVID-19 (2809)
C-suite (117)
Data (1393)
Diabetes (170)
Diagnostics (6700)
Earnings (94762)
Employer resources (167)
Events (127220)
Executive appointments (376)
FDA (18623)
Funding (431)
Gene therapy (218)
GLP-1 (698)
Government (5047)
Healthcare (20718)
Infectious disease (2901)
Inflammatory bowel disease (125)
Interviews (808)
IPO (17623)
Job creations (5180)
Job search strategy (2856)
Layoffs (492)
Legal (10044)
Lung cancer (200)
Manufacturing (219)
Medical device (14431)
Medtech (14436)
Mergers & acquisitions (22126)
Metabolic disorders (485)
Neuroscience (1694)
NextGen Class of 2024 (7647)
Non-profit (5065)
Northern California (1672)
Obesity (279)
Opinion (246)
Patents (122)
People (64297)
Pharmaceutical (142)
Phase I (22148)
Phase II (31207)
Phase III (23525)
Pipeline (515)
Postmarket research (3547)
Preclinical (10006)
Radiopharmaceuticals (256)
Rare diseases (277)
Real estate (7372)
Regulatory (26045)
Research institute (2641)
Resumes & cover letters (649)
Southern California (1454)
Startups (4276)
United States (15744)
Vaccines (658)
Weight loss (217)
Date
Today (79)
Last 7 days (704)
Last 30 days (2831)
Last 365 days (37677)
2024 (36740)
2023 (42568)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1264)
Arizona (228)
Asia (49450)
Australia (8715)
California (3869)
Canada (1429)
China (305)
Colorado (177)
Connecticut (181)
Europe (113206)
Florida (525)
Georgia (138)
Illinois (441)
Indiana (233)
Maryland (667)
Massachusetts (3116)
Michigan (182)
Minnesota (307)
New Jersey (1111)
New York (1082)
North Carolina (869)
Northern California (1672)
Ohio (150)
Pennsylvania (926)
South America (1647)
Southern California (1454)
Texas (564)
Utah (109)
Washington State (425)
833,074 Results for "cellinfinity bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Novel gene delivery technology published and licensed exclusively to Cellinfinity Bio
Cellinfinity Bio announced the publication of MAJESTIC, a technology that efficiently and with high cell health introduces genes into human genome, independent of CRISPR and lentiviral methods.
July 10, 2023
·
2 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Biotech Bay
Novel Chimeric Antigen Receptor Design Technology for CAR-T Cells Published and Licensed Exclusively to Cellinfinity Bio
Cellinfinity Bio, a privately held biotechnology company developing first/best-in-class cell therapy products against solid tumors and other diseases, today announced the publication of a novel CAR enhancement, the addition of CTLA-4 intracellular domain to improve anti-tumor CAR-T activity.
July 27, 2023
·
2 min read
Press Releases
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 24
December 13, 2024
·
1 min read
Pharm Country
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast
Annovis Bio Inc. today announced that it will host an investor webcast to discuss recent developments and future plans for its lead drug candidate, Buntanetap.
June 5, 2024
·
2 min read
Pharm Country
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
Azitra, Inc. today announced that management will present at the 2024 BIO International Convention being held June 3-6, 2024 in San Diego, California.
May 31, 2024
·
4 min read
Pharm Country
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
Annovis Bio Inc. today announced that it will host an investor webcast to discuss recent developments and future plans for its lead drug candidate, Buntanetap.
June 25, 2024
·
2 min read
Policy
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
Dallas, Texas--(Newsfile Corp. - June 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q1 2024.
June 4, 2024
·
1 min read
Biotech Bay
EditCo Bio, Inc. Expands Primary Cell Portfolio with Launch of Knockout CD8+ T-cell Pools
EditCo Bio, Inc., a leader in genome engineering innovation, announced the expansion of its T-cell editing portfolio with the launch of Knockout CD8+ T-cell Pools.
June 27, 2024
·
2 min read
Press Releases
Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics
November 25, 2024
·
5 min read
1 of 83,308
Next
